PharmaCyte Biotech Balance Sheet

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan '26 Jan 31, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021
Cash & Equivalents	20.17	15.17	50.18	68.04	85.4	2.2
Short-Term Investments	0.37	0.37	-	-	-	-
Cash & Short-Term Investments	20.54	15.54	50.18	68.04	85.4	2.2
Cash Growth	22.57%	-69.03%	-26.25%	-20.33%	3778.14%	146.08%
Other Receivables	-	3.7	-	-	-	-
Total Trade Receivables	-	3.7	-	-	-	-
Other Current Assets	0.16	3.14	0.26	0.11	0.09	0.07
Total Current Assets	20.7	22.38	50.44	68.15	85.49	2.28
Other Intangible Assets	1.55	1.55	1.55	3.55	3.55	3.55
Long-Term Investments	22.47	22.47	-	1.57	1.57	1.57
Other Long-Term Assets	12.71	10.32	9.46	3.56	3.56	3.56
Total Assets	55.87	55.17	59.9	73.28	90.62	7.4
Accounts Payable	1.2	0.4	0.39	0.13	0.21	0.17
Accrued Expenses	0.45	2.52	0.74	0.46	0.5	0.55
Other Current Liabilities	0.03	-	6.3	-	-	-
Total Current Liabilities	1.68	2.91	7.42	0.59	0.7	0.72
Other Long-Term Liabilities	14.79	0.36	12.97	-	-	-
Total Long-Term Liabilities	14.79	0.36	12.97	-	-	-
Total Liabilities	16.47	3.28	20.39	0.59	0.7	0.72
Common Stock	0	0	0	0	0	0
Treasury Stock	-45.01	-44.61	-42.04	-13.56	-	-
Additional Paid-in Capital	183.14	181.49	185.33	202.23	201.58	114.11
Accumulated Other Comprehensive Income	-0.02	-0.02	-0.02	-0.02	-0.02	-0.02
Retained Earnings	-100	-84.97	-115.63	-115.96	-111.65	-107.41
Total Common Shareholders' Equity	38.11	51.89	27.65	72.69	89.92	6.68
Minority Interest	1.29	-	11.87	-	-	-
Shareholders' Equity	39.4	51.89	39.51	72.69	89.92	6.68
Total Liabilities & Equity	55.87	55.17	59.9	73.28	90.62	7.4
Net Cash (Debt)	20.54	15.54	50.18	68.04	85.4	2.2
Net Cash Growth	32.17%	-69.03%	-26.25%	-20.33%	3778.14%	168.66%
Net Cash Per Share	2.77	2.12	5.24	131.51	165.06	45.62
Book Value	38.11	51.89	27.65	72.69	89.92	6.68
Book Value Per Share	5.13	7.08	2.89	140.49	173.80	138.36
Tangible Book Value	36.56	50.34	26.1	69.14	86.37	3.13
Tangible Book Value Per Share	4.92	6.87	2.72	133.63	166.94	64.84

Updated Jan 31, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q